Viewing nowAtorine Tablets 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Optus Pharmaceutical Co., Ltd.

MFDS item code 201601007 · Approved 2016.02.23 · Insurance code 674101390
Improves hyperlipidemia and helps prevent cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication reduces the risks of myocardial infarction, stroke, the need for vascular revascularization, angina, and hospitalization for congestive heart failure in adults with multiple risk factors related to cardiovascular disease and patients with type 2 diabetes. It also lowers total cholesterol, LDL cholesterol, and triglyceride levels, while raising HDL cholesterol levels in patients with primary hypercholesterolemia and dyslipidemia, thereby supporting cardiovascular health. It is also used to decrease total cholesterol and LDL cholesterol levels in certain pediatric patients aged 10 to 17. Overall, this medication helps to reduce the risk of cardiovascular disease and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is only for patients requiring an LDL cholesterol reduction of 45 % or greater). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient’s characteristics, taking into account the treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such lipid-lowering therapies are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may pose a risk of muscle problems; therefore, if symptoms of muscle pain or weakness occur, immediate discontinuation and consultation with a physician are required. This medication should not be used in women with certain conditions, during pregnancy, during breastfeeding, or in children under 10 years of age. Patients with liver or kidney function issues should use this medication with caution, and regular monitoring of liver function and muscle condition is important. Interactions may occur when taken with other medications, so patients should inform their doctor or pharmacist of any medications they are currently taking. It is recommended to avoid or limit alcohol intake during the medication course, and excessive grapefruit juice should also be avoided. Women who may become pregnant should use appropriate contraceptive methods while taking this medication, and if pregnancy is confirmed, the medication should be discontinued immediately. Women who are breastfeeding should not take this medication, and special caution is needed for children and older adults when using this medication. There is no specific antidote for overdose, so in case of overdosage, it is essential to visit a medical institution immediately for treatment based on symptoms. Keep this medication out of reach of children, and it is safest to store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it should be kept in a temperature range of 1 to 30 degrees Celsius, avoiding excessively hot or cold places.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Optus Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.